Electrophoresis Reagents Market Size

Electrophoresis Reagents Market Analysis

The Electrophoresis Reagents Market is expected to register a CAGR of 5.11% during the forecast period.

Globally, the outbreak of COVID-19 was an incomparable public health emergency that affected the healthcare industry. The pandemic has had a notable impact on the market growth as electrophoresis techniques were used to develop effective therapies to separate DNA, RNA, or protein molecules based on their size for effective therapies against COVID-19. For instance, as per the National Clinical Trial (NCT) Registry updated in July 2022, Elsan conducted a clinical trial to assess serum inflammation profiles by protein electrophoresis on patients hospitalized for infection due to the SARS-CoV-2 virus. Such increasing research and development activities in developing effective therapies were expected to increase the demand for electrophoresis reagents during the COVID-19 pandemic. In addition, gel electrophoresis with other diagnostic technology was used to detect COVID-19. According to the study published in NCBI in November 2021, applying conventional PCR in conjunction with gel-electrophoresis for testing analysis is a possible approach for making SARS-CoV-2 diagnostics available worldwide. As a result, during the COVID-19 pandemic, the need for coronavirus disease diagnosis increased. This trend is expected to continue during the forecast period owing to the emergence of multiple variants, propelling the market growth.

The major factors driving the electrophoresis reagents market include the increasing funding for genomic and proteomic research; the rising prevalence of chronic diseases; increasing collaborations between industry and academia; and technological developments. According to the World Health Organization factsheet published in February 2022, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States. The report also mentioned that each year, approximately 400,000 children develop cancer globally. Cervical cancer is the most common in 23 countries, such as Eswatini, India, South Africa, Latin America, and others. The most common cancers are breast, lung, colon and rectum, and prostate cancers.

Additionally, for instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, in Asia and Australia 310 million. As the prevalence of chronic diseases increases, researchers continue to focus on providing prospective treatment options through research and development, which raises the need for gel electrophoresis, and electrophoresis reagents, consequently promoting the market's growth.

Additionally, technological advancement in electrophoresis instruments further propels the market's growth. For instance, in September 2021, a novel capillary electrophoresis system, BioPhase8800, was introduced by Sciex Company for biological characterization during biopharmaceutical therapy. The new device analyses eight samples simultaneously and is a multi-capillary system for Capillary Electrophoresis Sodium Dodecyl Sulfate (CE-SDS).

Therefore, factors like increasing funding for genomic and proteomic research, the rising prevalence of chronic diseases, and technological developments are expected to promote the growth of the electrophoresis reagents market over the forecast period. However, time-consuming operations and the availability of other alternatives may restrain the market's growth over the forecast period.